Literature DB >> 8292535

The role of the mesonephros in cell differentiation and morphogenesis of the mouse fetal testis.

H Merchant-Larios1, N Moreno-Mendoza, M Buehr.   

Abstract

In mouse fetal gonads, the adjacent mesonephros is required for seminiferous cord formation in vitro (Buehr et al., Development 117: 273-281, 1993). Here, we have investigated the role of mesonephric cells in seminiferous cord formation and in differentiation of Sertoli and Leydig cells. Undifferentiated male gonads with and without mesonephros at 11.5 dpc were cultured and immunocytochemical staining of Müllerian-inhibiting substance (MIS) was used as the criterion for Sertoli cell differentiation. For Leydig cells, testosterone (T) radioimmunoassay and cytochemical detection of delta 5-3 beta-hydroxysteroid-dehidrogenase (HSD) were undertaken. An ultrastructural study was also performed. In our culture conditions, the timing of differentiation of both Sertoli and Leydig cells was similar to that in the fetus. Although mesonephros is required for seminiferous cord formation, differentiation of Sertoli and Leydig cells proceeds in its absence at 11.5 dpc. Moreover, when 3H-thymidine labeled mesonephroi were grafted to unlabeled gonads, endothelial and peritubular myoid-like cells migrated into the gonad. We propose that these cells might be the mesonephric cells required for seminiferous cord formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292535

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  18 in total

1.  Neutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis.

Authors:  Michelle M Baltes-Breitwisch; Robin A Artac; Rebecca C Bott; Renee M McFee; Jill G Kerl; Debra T Clopton; Andrea S Cupp
Journal:  Reproduction       Date:  2010-05-10       Impact factor: 3.906

Review 2.  Environmental epigenetics and effects on male fertility.

Authors:  Carlos Guerrero-Bosagna; Michael K Skinner
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

3.  A deficiency of lunatic fringe is associated with cystic dilation of the rete testis.

Authors:  K L Hahn; B Beres; Megan J Rowton; M K Skinner; Y Chang; A Rawls; J Wilson-Rawls
Journal:  Reproduction       Date:  2008-09-18       Impact factor: 3.906

4.  Two distinct origins for Leydig cell progenitors in the fetal testis.

Authors:  Tony DeFalco; Satoru Takahashi; Blanche Capel
Journal:  Dev Biol       Date:  2011-01-19       Impact factor: 3.582

5.  Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat.

Authors:  Rebecca C Bott; Ryann M McFee; Debra T Clopton; Candice Toombs; Andrea S Cupp
Journal:  Biol Reprod       Date:  2006-05-03       Impact factor: 4.285

6.  AMH induces mesonephric cell migration in XX gonads.

Authors:  Andrea J Ross; Christopher Tilman; Humphrey Yao; David MacLaughlin; Blanche Capel
Journal:  Mol Cell Endocrinol       Date:  2003-12-15       Impact factor: 4.102

7.  Peritubular myoid cells are not the migrating population required for testis cord formation in the XY gonad.

Authors:  J Cool; F D Carmona; J C Szucsik; B Capel
Journal:  Sex Dev       Date:  2008-09-03       Impact factor: 1.824

8.  Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis.

Authors:  Humphrey Hung-Chang Yao; Wendy Whoriskey; Blanche Capel
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

Review 9.  At the Crossroads of Fate-Somatic Cell Lineage Specification in the Fetal Gonad.

Authors:  Emmi Rotgers; Anne Jørgensen; Humphrey Hung-Chang Yao
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 10.  A proposed role for VEGF isoforms in sex-specific vasculature development in the gonad.

Authors:  R C Bott; D T Clopton; A S Cupp
Journal:  Reprod Domest Anim       Date:  2008-07       Impact factor: 2.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.